Contacter le RP

Pour utiliser cette fonctionnalité, vous devez bénéficier d'un compte Babbler.


Babbler permet aux journalistes et communicants de collaborer plus simplement.

En vous connectant, vous pourrez accéder gratuitement aux espaces presse des centaines d'entreprises de vos secteurs qui sont sur Babbler, entrer en contact direct avec leurs équipes RP mais aussi y partager vos prochains sujets !

Leurs espaces presse sont sur Babbler :

Vous êtes à 1 clic de l'inscription !


Content de vous revoir !


Global Radiopharmaceuticals Market To Be Driven By The Rising Demand For Timely And Accurate Detection Of Fatal Diseases In The Forecast Period Of 2022-2027
timer minutes de lecture minute de lecture

Copier le lien
Global Radiopharmaceuticals Market, Share, Price, Trends, Growth, Analysis, Key Players, Outlook, Report, Forecast 2022-2027 | EMR Inc.

The new report by Expert Market Research titled, 'Global Radiopharmaceuticals Market Report and Forecast 2022-2027', gives an in-depth analysis of the global  radiopharmaceuticals market , assessing the radiopharmaceuticals market based on its segments like generator types, applications, end uses, and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analyzing the market based on the SWOT and Porter's Five Forces models.

Request a free sample copy in PDF or view the report summary@

The key highlights of the report include:

Market Overview (2017-2027)

  • Historical Market Size (2020): About USD 4.3 trillion
  • Forecast CAGR (2022-2027): 7.5%

The growing market of radiopharmaceuticals is being led by a significant share held by North America. This can be ascribed to the presence of leading market players and well-funded research facilities in the region. With regular advances in the healthcare sector, the region is likely to maintain dominance in the coming years as well. Further, on the basis of region, the Asia Pacific region is anticipated to grow at a significant pace during the forecast period. Furthermore, owing to the commonality of thyroid-related disorders, the SPECT segment among the diagnostic radiopharmaceuticals is anticipated to propel the market during the forecast period.Moreover, with the year-by-year rise in cancer patients, the oncology segment is expected to witness significant growth in the coming years, thereby contributing to the market growth.

Industry Definition and Segmentation

A radiopharmaceutical is defined as a group of pharmaceutical drugs that contains radioisotopes. Also known as medicinal radiocompounds, radiopharmaceuticals can be used as a diagnostic medication as well as a therapeutic agent for both chronic and critical diseases.

Based on generators type, the market can be segmented into:

  • W-188/Re-188 Generators
  • Mo-99/Tc-99m Generators
  • Sr-82/Rb-82 Generators
  • Sr-90/Y-90 Generators
  • Ge-68/Ga-67,68 Generators

On the basis of application, the market can be divided into:

  • Diagnosis Radiopharmaceuticals
    • SPECT (Single-Photon Emission Computed Tomography)
    • PET (Positron Emission Tomography)
  • Therapeutic Radiopharmaceuticals
    • Oncology
    • Cardiology and Neurology
  • Theranostics

The major end use segments of radiopharmaceuticals are:

  • Hospitals
  • Diagnosis Centers

The regional markets for radiopharmaceuticals include:

  • North America
  • Europe
  • Asia Pacific
  • latin america
  • Middle East and Africa

Market Trends

The radiopharmaceutical segment is the fastest-growing segment of the overall pharmaceutical industry. This can be associated with the rising demand for timely diagnostics and treatment of diseases owing to the increasing prevalence of chronic and fatal disorders. As a result, the revolutionary utilization of radiopharmaceuticals in diagnostics is gaining popularity in the healthcare sector. Furthermore, the rising acceptance of disease-specific therapy, enhanced patient awareness regarding accurate and timely diagnosis, and expanding applications of molecular imaging are additional factors invigorating the growth of radiopharmaceuticals.

Key Market Players

The major players in the market are Jubilant Pharma Holdings Inc., Clarity Pharmaceuticals, and Cardinal Health, among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

About Us:

Expert Market Research is a leading business intelligence firm, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally.

At Expert Market Research, we tailor our approach according to our clients' needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.


Company Name: Claight Corporation
Contact Person: Louis Wane, Corporate Sales Specialist – USA
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

Autres actualités de la marque

inscrit avec succès

Félicitations, vous êtes inscrit sur BABBLER !

Pour découvrir dès maintenant toutes les actualités qui vous attendent sur Babbler, consultez votre newsfeed !

Vos domaines ont été préselectionnés. Vous pouvez les compléter en cliquant ici